Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Metastatic Castration-resistant Prostate Cancer 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 4Oncolytic Virotherapy 4Cisplatin 4Cetuximab 3Radiotherapy 2Positron Emission Tomography Computed Tomography 2Nivolumab 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Fluorouracil 2Erlotinib Hydrochloride 2Docetaxel 2technetium 99m ethylenedicysteine deoxyglucose 1ruxolitinib 1dornase alfa 1avelumab 1alovudine 1Varenicline 1VTX-2337 1Tobacco Use Cessation Devices 1Tetrahydrouridine 1TAK-981 1Ropivacaine 1Raltegravir Potassium 1Pyrimethamine 1Postmortem Imaging 1Positron-Emission Tomography 1Paclitaxel 1Oxycodone 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Head and Neck Neoplasms × alovudine × Clear all
NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Mayo Clinic

Phase EARLY_PHASE1 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡